P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY

Detalles Bibliográficos
Autores principales: Hungria, Vania, Weisel, Katja, Currie, Brooke, Perera, Sue, Sule, Neal, He, Wei, Mckeown, Astrid, Sapra, Sandhya, Nelsen, Linda, LI, Mary, Barale, Sophie, Boyle, Julia, Mcpoyle, Kaytlyn, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431560/
http://dx.doi.org/10.1097/01.HS9.0000970760.35249.ae

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431560/
http://dx.doi.org/10.1097/01.HS9.0000970760.35249.ae

Ejemplares similares